As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Shenade
Legendary User
2 hours ago
Why didn’t I see this earlier?! 😭
👍 144
Reply
2
Joseff
Daily Reader
5 hours ago
I read this like I had responsibilities.
👍 153
Reply
3
Denziel
Community Member
1 day ago
I had a feeling I missed something important… this was it.
👍 223
Reply
4
Lennyn
Insight Reader
1 day ago
Innovation at its peak! 🚀
👍 69
Reply
5
Jaxyla
Loyal User
2 days ago
Real-time US stock alerts and notifications ensuring you never miss important price movements or market opportunities. Our customizable alert system lets you monitor specific stocks, sectors, or market conditions that matter most to your investment strategy.
👍 15
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.